Clinical Trials Directory

Trials / Completed

CompletedNCT03544086

Clinical Evaluation of a Wearable Sleep Diagnosis Technology

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Acurable Ltd. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The primary endpoint is to evaluate the sensitivities and specificities for diagnosis of sleep apnoea of a wearable sleep diagnosis technology vs. existing gold standard.

Detailed description

The clinical investigation will be performed at the Royal Free London Hospital. Physiological signals will be pseudo-anonymized and only viewed by the research team. The Study will involve patients who will have been referred for diagnosis of sleep apnoea, will aim to determine AcuPebble's positive and negative predictive ratios, sensitivities as specificities. Likelihood ratios for diagnosis of sleep apnoea. Clinical experts will determine patients' diagnostic information using the current diagnostic standards. AcuPebble will also generate diagnostic results independently and automatically. Both set of results will be subsequently compared and the relevant performance metrics listed above will be determined. Consecutive patients referred for sleep study will be recruited to the study. Patients that are willing to participate will be consented on the day of their sleep study and sent home with both - the Trusts usual multichannel polygraphy and the Acupebble.

Conditions

Timeline

Start date
2018-07-10
Primary completion
2019-12-30
Completion
2020-09-15
First posted
2018-06-01
Last updated
2020-12-04

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03544086. Inclusion in this directory is not an endorsement.